Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group

Eric H Kossoff, Beth A Zupec-Kania, Stéphane Auvin, Karen R Ballaban-Gil, A G Christina Bergqvist, Robyn Blackford, Jeffrey R Buchhalter, Roberto H Caraballo, J Helen Cross, Maria G Dahlin, Elizabeth J Donner, Orkide Guzel, Rana S Jehle, Joerg Klepper, Hoon-Chul Kang, Danielle A Lambrechts, Y M Christiana Liu, Janak K Nathan, Douglas R Nordli Jr, Heidi H Pfeifer, Jong M Rho, Ingrid E Scheffer, Suvasini Sharma, Carl E Stafstrom, Elizabeth A Thiele, Zahava Turner, Maria M Vaccarezza, Elles J T M van der Louw, Pierangelo Veggiotti, James W Wheless, Elaine C Wirrell, Charlie Foundation, Matthew's Friends, Practice Committee of the Child Neurology Society, Eric H Kossoff, Beth A Zupec-Kania, Stéphane Auvin, Karen R Ballaban-Gil, A G Christina Bergqvist, Robyn Blackford, Jeffrey R Buchhalter, Roberto H Caraballo, J Helen Cross, Maria G Dahlin, Elizabeth J Donner, Orkide Guzel, Rana S Jehle, Joerg Klepper, Hoon-Chul Kang, Danielle A Lambrechts, Y M Christiana Liu, Janak K Nathan, Douglas R Nordli Jr, Heidi H Pfeifer, Jong M Rho, Ingrid E Scheffer, Suvasini Sharma, Carl E Stafstrom, Elizabeth A Thiele, Zahava Turner, Maria M Vaccarezza, Elles J T M van der Louw, Pierangelo Veggiotti, James W Wheless, Elaine C Wirrell, Charlie Foundation, Matthew's Friends, Practice Committee of the Child Neurology Society

Abstract

Ketogenic dietary therapies (KDTs) are established, effective nonpharmacologic treatments for intractable childhood epilepsy. For many years KDTs were implemented differently throughout the world due to lack of consistent protocols. In 2009, an expert consensus guideline for the management of children on KDT was published, focusing on topics of patient selection, pre-KDT counseling and evaluation, diet choice and attributes, implementation, supplementation, follow-up, side events, and KDT discontinuation. It has been helpful in outlining a state-of-the-art protocol, standardizing KDT for multicenter clinical trials, and identifying areas of controversy and uncertainty for future research. Now one decade later, the organizers and authors of this guideline present a revised version with additional authors, in order to include recent research, especially regarding other dietary treatments, clarifying indications for use, side effects during initiation and ongoing use, value of supplements, and methods of KDT discontinuation. In addition, authors completed a survey of their institution's practices, which was compared to responses from the original consensus survey, to show trends in management over the last 10 years.

Keywords: Children; Diet; Epilepsy; Guideline; Ketogenic.

References

    1. Wilder RM. The effect of ketonemia on the course of epilepsy. Mayo Clin Bulletin 1921;2:307–308.
    1. Neal EG, Chaffe HM, Schwartz RH, et al. The ketogenic diet in the treatment of epilepsy in children: a randomised, controlled trial. Lancet Neurol 2008;7:500–506.
    1. Freeman JM, Vining EP, Kossoff EH, et al. A blinded, crossover study of the efficacy of the ketogenic diet. Epilepsia 2009;50:322–325.
    1. Sharma S, Sankhyan N, Gulati S, et al. Use of the modified Atkins diet for treatment of refractory childhood epilepsy: a randomized controlled trial. Epilepsia 2013;54:481–486.
    1. Lambrechts DA, de Kinderen RJ, Vles JS, et al. A randomized controlled trial of the ketogenic diet in refractory childhood epilepsy. Acta Neurol Scand 2017;135:231–239.
    1. Kossoff EH, Turner Z, Doerrer SC, et al. The ketogenic and modified atkins diets: treatments for epilepsy and other disorders. New York: Demos Health; 2016.
    1. Whitmer E, Riether JL. Fighting back with Fat: a parent's guide to battling epilepsy through the ketogenic diet and modified Atkins diet. New York: Demos Health; 2013.
    1. Martenz DM, Cramp L. The Keto Cookbook: innovative delicious meals for staying on the ketogenic diet. New York: Demos Health; 2012.
    1. Klepper J, Leiendecker B, Riemann E, et al. The ketogenic diet in German‐speaking countries: update 2003. Klin Padiatr 2004;216:277–285.
    1. Kossoff EH, Zupec‐Kania BA, Amark PE, et al. Optimal clinical management of children receiving the ketogenic diet: recommendations of the international ketogenic diet study group. Epilepsia 2009;50:304–317.
    1. Thompson L, Fecske E, Salim M, et al. Use of the ketogenic diet in the neonatal intensive care unit‐Safety and tolerability. Epilepsia 2017;58:e36–e39.
    1. Dressler A, Trimmel‐Schwahofer P, Reithofer E, et al. The ketogenic diet in infants—Advantages of early use. Epilepsy Res 2015;116:53–58.
    1. Kim JA, Yoon JR, Lee EJ, et al. Efficacy of the classic ketogenic and the modified Atkins diets in refractory childhood epilepsy. Epilepsia 2016;57:51–58.
    1. van der Louw E, van den Hurk D, Neal E, et al. Ketogenic diet guidelines for infants with refractory epilepsy. Eur J Paediatr Neurol 2016;20:798–809.
    1. Barborka CJ. Epilepsy in adults: results of treatment by ketogenic diet in one hundred cases. Arch Neurol 1930;6:904–914.
    1. Nei M, Ngo L, Sirven JI, et al. Ketogenic diet in adolescents and adults with epilepsy. Seizure 2014;23:439–442.
    1. Mady MA, Kossoff EH, McGregor AL, et al. The ketogenic diet: adolescents can do it, Too. Epilepsia 2003;44:847–851.
    1. Kossoff EH, Rowley H, Sinha SR, et al. A prospective study of the modified Atkins diet for intractable epilepsy in adults. Epilepsia 2008;49:316–319.
    1. Lambrechts DA, Wielders LH, Aldenkamp AP, et al. The ketogenic diet as a treatment option in adults with chronic refractory epilepsy: efficacy and tolerability in clinical practice. Epilepsy Behav 2012;23:310–314.
    1. Klein P, Tyrlikova I, Mathews GC. Dietary treatment in adults with refractory epilepsy: a review. Neurology 2014;83:1978–1985.
    1. Schoeler NE, Wood S, Aldridge V, et al. Ketogenic dietary therapies for adults with epilepsy: feasibility and classification of response. Epilepsy Behav 2014;37:77–81.
    1. Cervenka MC, Henry BJ, Felton EA, et al. Establishing an Adult Epilepsy Diet Center: experience, efficacy and challenges. Epilepsy Behav 2016;58:61–68.
    1. Kossoff EH, Henry BJ, Cervenka MC. Transitioning pediatric patients receiving ketogenic diets for epilepsy into adulthood. Seizure 2013;22:487–489.
    1. Kossoff EH, McGrogan JR, Bluml RM, et al. A modified Atkins diet is effective for the treatment of intractable pediatric epilepsy. Epilepsia 2006;47:421–424.
    1. Pfeifer HH, Thiele EA. Low‐glycemic‐index treatment: a liberalized ketogenic diet for treatment of intractable epilepsy. Neurology 2005;65:1810–1812.
    1. Lemmon ME, Terao NN, Ng YT, et al. Efficacy of the ketogenic diet in Lennox‐Gastaut syndrome: a retrospective review of one institution's experience and summary of the literature. Dev Med Child Neurol 2012;54:464–468.
    1. Klepper J, Leiendecker B. GLUT1 deficiency syndrome – 2007 update. Dev Med Child Neurol 2007;49:707–716.
    1. Sofou K, Dahlin M, Hallböök T, et al. Ketogenic diet in pyruvate dehydrogenase complex deficiency: short‐ and long‐term outcomes. J Inherit Metab Dis 2017;40:237–245.
    1. Arsov T, Mullen SA, Rogers S, et al. Glucose transporter 1 deficiency in the idiopathic generalized epilepsies. Ann Neurol 2012;72:807–815.
    1. Klepper J, Leiendecker B. Glut1 deficiency syndrome and novel ketogenic diets. J Child Neurol 2013;28:1045–1048.
    1. Kass HR, Winesett SP, Bessone SK, et al. Use of dietary therapies amongst patients with GLUT1 deficiency syndrome. Seizure 2016;35:83.
    1. Leen WG, Taher M, Verbeek MM, et al. GLUT1 deficiency syndrome into adulthood: a follow‐up study. J Neurol 2014;261:589–599.
    1. Pascual JM, Liu P, Mao D, et al. Triheptanoin for glucose transporter type I deficiency (G1D): modulation of human ictogenesis, cerebral metabolic rate, and cognitive indices by a food supplement. JAMA Neurol 2014;71:1255–1265.
    1. Oguni H, Tanaka T, Hayashi K, et al. Treatment and long‐term prognosis of myoclonic‐astatic epilepsy of early childhood. Neuropediatrics 2002;33:122–132.
    1. Dressler A, Trimmel‐Schwahofer P, Reithofer E, et al. Efficacy and tolerability of the ketogenic diet in Dravet syndrome – Comparison with various standard antiepileptic drug regimen. Epilepsy Res 2015;109:81–89.
    1. Caraballo RH, Cersosimo RO, Sakr D, et al. Ketogenic diet in patients with Dravet syndrome. Epilepsia 2005;46:1539–1544.
    1. Caraballo RH, Cersosimo RO, Sakr D, et al. Ketogenic diet in patients with myoclonic‐astatic epilepsy. Epileptic Disord 2006;8:151–155.
    1. Kilaru S, Bergqvist AG. Current treatment of myoclonic astatic epilepsy: clinical experience at the children's hospital of Philadelphia. Epilepsia 2007;48:1703–1707.
    1. Eun SH, Kang HC, Kim DW, et al. Ketogenic diet for treatment of infantile spasms. Brain Dev 2006;28:566–571.
    1. Hong AM, Turner Z, Hamdy RF, et al. Infantile spasms treated with the ketogenic diet: prospective single‐center experience in 104 consecutive infants. Epilepsia 2010;51:1403–1407.
    1. Kossoff EH, Thiele EA, Pfeifer HH, et al. Tuberous sclerosis complex and the ketogenic diet. Epilepsia 2005;46:1684–1686.
    1. Coppola G, Klepper J, Ammendola E, et al. The effects of the ketogenic diet in refractory partial seizures with reference to tuberous sclerosis. Eur J Paediatr Neurol 2006;10:148–151.
    1. Kossoff EH, Turner Z, Bergey GK. Home‐guided use of the ketogenic diet in a patient for over twenty years. Pediatr Neurol 2007;36:424–425.
    1. Ismail FY, Kossoff EH. AERRPS, DESC, NORSE, FIRES: multi‐labeling or distinct epileptic entities? Epilepsia 2011;52:e185–e189.
    1. Millichap JJ, Millichap JG. Ketogenic diet as preferred treatment of FIRES. Pediatr Neurol Briefs 2015;29:3.
    1. Nabbout R, Mazzuca M, Hubert P, et al. Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES). Epilepsia 2010;51:2033–2037.
    1. Singh RK, Joshi SM, Potter DM, et al. Cognitive outcomes in febrile infection‐related epilepsy syndrome treated with the ketogenic diet. Pediatrics 2014;134:e1431–e1435.
    1. Hosain SA, La Vega‐Talbott M, Solomon GE. Ketogenic diet in pediatric epilepsy patients with gastrostomy feeding. Pediatr Neurol 2005;32:81–83.
    1. Kossoff EH, McGrogan JR, Freeman JM. Benefits of an all‐liquid ketogenic diet. Epilepsia 2004;45:1163.
    1. Sivaraju A, Nussbaum I, Cardoza CS, et al. Substantial and sustained seizure reduction with ketogenic diet in a patient with Ohtahara syndrome. Epilepsy Behav Case Rep 2015;3:43–45.
    1. Seo JH, Lee YM, Lee JS, et al. A case of Ohtahara syndrome with mitochondrial respiratory chain complex I deficiency. Brain Dev 2010;32:253–257.
    1. Ishii M, Shimono M, Senju A, et al. The ketogenic diet as an effective treatment for Ohtahara syndrome. No To Hattatsu 2011;43:47–50.
    1. Thakur KT, Probasco JC, Hocker SE, et al. Ketogenic diet for adults in super‐refractory status epilepticus. Neurology 2014;82:665–670.
    1. Caraballo R, Darra F, Reyes G, et al. The ketogenic diet in patients with myoclonic status in non‐progressive encephalopathy. Seizure 2017;51:1–5.
    1. Kang HC, Lee YM, Kim HD, et al. Safe and effective use of the ketogenic diet in children with epilepsy and mitochondrial respiratory chain complex defects. Epilepsia 2007;48:82–88.
    1. Grocott OR, Herrington KS, Pfeifer HH, et al. Low glycemic index treatment for seizure control in Angelman syndrome: A case series from the Center for Dietary Therapy of Epilepsy at the Massachusetts General Hospital. Epilepsy Behav 2017;68:45–50.
    1. Evangeliou A, Doulioglou V, Haidopoulou K, et al. Ketogenic diet in a patient with Angelman syndrome. Pediatr Int 2010;52:831–834.
    1. Cardinali S, Canafoglia L, Bertoli S, et al. A pilot study of a ketogenic diet in patients with Lafora body disease. Epilepsy Res 2006;69:129–134.
    1. Liebhaber GM, Riemann E, Baumeister FA. Ketogenic diet in Rett syndrome. J Child Neurol 2003;18:74–75.
    1. Giampietro PF, Schowalter DB, Merchant S, et al. Widened clinical spectrum of the Q128P MECP2 mutation in Rett syndrome. Childs Nerv Syst 2006;22:320–324.
    1. Bergqvist AG, Chee CM, Lutchka LM, et al. Treatment of acquired epileptic aphasia with the ketogenic diet. J Child Neurol 1999;14:696–701.
    1. Bautista RE. The use of the ketogenic diet in a patient with subacute sclerosing panencephalitis. Seizure 2003;12:175–177.
    1. Swoboda KJ, Specht L, Jones HR, et al. Infantile phosphofructokinase deficiency with arthrogryposis: clinical benefit of a ketogenic diet. J Pediatr 1997;131:932–934.
    1. Jurecka A, Opoka‐Winiarska V, Rokicki D, et al. Neurologic presentation, diagnostics, and therapeutic insights in a severe case of adenylosuccinate lyase deficiency. J Child Neurology 2012;27:645–649.
    1. Busch V, Gempel K, Hack A, et al. Treatment of glycogenosis type V with ketogenic diet. Ann Neurol 2005;58:341.
    1. Kossoff EH, Henry BJ, Cervenka MC. Efficacy of dietary therapy for juvenile myoclonic epilepsy. Epilepsy Behav 2013;26:162–164.
    1. Lim Z, Wong K, Olson HE, et al. Use of the ketogenic diet to manage refractory epilepsy in CDKL5 disorder: Experience of >100 patients. Epilepsia 2017;58:1415–1422.
    1. Caraballo R, Noli D, Cachia P. Epilepsy of infancy with migrating focal seizures: three patients treated with the ketogenic diet. Epileptic Disord 2015;17:194–197.
    1. Groomes LB, Pyzik PL, Turner Z, et al. Do patients with absence epilepsy respond to ketogenic diets? J Child Neurol 2011;26:160–165.
    1. Kelley SA, Kossoff EH. How effective is the ketogenic diet for electrical status epilepticus of sleep? Epilepsy Res 2016;127:339–343.
    1. Tein I. Role of carnitine and fatty acid oxidation and its defects in infantile epilepsy. J Child Neurol 2002;17(Suppl. 3):S57–S82.
    1. Baumeister FA, Oberhoffer R, Liebhaber GM, et al. Fatal propofol infusion syndrome in association with ketogenic diet. Neuropediatrics 2004;35:250–252.
    1. Stainman RS, Turner Z, Rubenstein JE, et al. Decreased relative efficacy of the ketogenic diet for children with surgically approachable epilepsy. Seizure 2007;16:615–619.
    1. Jung DE, Kang HC, Kim HD. Long‐term outcome of the ketogenic diet for intractable childhood epilepsy with focal malformation of cortical development. Pediatrics 2008;122:e330–e333.
    1. Stafstrom CE, Rho JM. The ketogenic diet as a treatment paradigm for diverse neurological disorders. Front Pharmacol 2012;3:59.
    1. van der Louw EJTM, Williams TJ, Henry‐Barron BJ, et al. Ketogenic diet therapy for epilepsy during pregnancy: a case series. Seizure 2017;45:198–201.
    1. Kossoff EH, Doerrer SS, Turner Z. How do parents find out about the ketogenic diet? Epilepsy Behav 2012;24:445–448.
    1. Farasat S, Kossoff EH, Pillas DJ, et al. The importance of cognition in parental expectations prior to starting the ketogenic diet. Epilepsy Behav 2006;8:406–410.
    1. Lin A, Turner Z, Doerrer SC, et al. Complications during ketogenic diet initiation: prevalence, treatment, and influence on seizure outcomes. Pediatr Neurol 2017;68:35–39.
    1. Kossoff EH, Sutter L, Doerrer SC, et al. Impact of Child Life services on children and families admitted to start the ketogenic diet. J Child Neurol 2017;32:828–833.
    1. Huttenlocher P. Ketonemia and seizures: Metabolic and anticonvulsant effects of two ketogenic diets in childhood epilepsy. Pediatr Res 1976;10:536–540.
    1. Schwartz RH, Eaton J, Bower BD, et al. Ketogenic diets in the treatment of epilepsy: short‐term clinical effects. Dev Med Child Neurol 1989;1:145–151.
    1. Neal EG, Chaffe H, Schwartz RH, et al. A randomized trial of classical and medium‐chain triglyceride ketogenic diets in the treatment of childhood epilepsy. Epilepsia 2009;50:1109–1117.
    1. Neal EG, Chaffe HM, Edwards N, et al. Growth of children on classical and medium chain triglyceride diets. Pediatrics 2008;122:e334–e340.
    1. Seo JH, Lee YM, Lee JS, et al. Efficacy and tolerability of the ketogenic diet according to lipid:nonlipid ratios–comparison of 3:1 with 4:1 diet. Epilepsia 2007;48:801–805.
    1. Vaisleib II, Buchhalter JR, Zupanc ML. Ketogenic diet: outpatient initiation, without fluid, or caloric restrictions. Pediatr Neurol 2004;31:198–202.
    1. Bansal S, Cramp L, Blalock D, et al. The ketogenic diet: initiation at goal calories versus gradual caloric advancement. Pediatr Neurol 2014;50:26–30.
    1. Sell E, Liu YMC, Donner E, et al. The medium‐chain triglyceride ketogenic diet for the treatment of refractory lesional epilepsy in children. Epilepsia 2005;46:234.
    1. Kang HC, Lee HS, You SJ, et al. Use of a modified Atkins diet in intractable childhood epilepsy. Epilepsia 2007;48:182–186.
    1. Kossoff EH, Turner Z, Bluml RM, et al. A randomized, crossover comparison of daily carbohydrate limits using the modified Atkins diet. Epilepsy Behav 2007;10:432–436.
    1. Sharma S, Goel S, Jain P, et al. Evaluation of a simplified modified Atkins diet for use by parents with low levels of literacy in children with refractory epilepsy: a randomized controlled trial. Epilepsy Res 2016;127:152–159.
    1. Sharma S, Sankhyan N, Gulati S, et al. Use of the modified Atkins diet in infantile spasms refractory to first‐line treatment. Seizure 2012;21:45–48.
    1. Mehta R, Goel S, Sharma S, et al. Efficacy and tolerability of the modified Atkins diet in young children with refractory epilepsy: Indian experience. Ann Indian Acad Neurol 2016;19:523–527.
    1. Muzykewicz DA, Lyczkowski DA, Memon N, et al. Efficacy, safety, and tolerability of the low glycemic index treatment in pediatric epilepsy. Epilepsia 2009;50:1118–1126.
    1. Coppola G, D'Aniello A, Messana T, et al. Low glycemic index diet in children and young adults with refractory epilepsy: first Italian experience. Seizure 2011;20:526–528.
    1. Karimzadeh P, Sedighi M, Beheshti M, et al. Low Glycemic Index Treatment in pediatric refractory epilepsy: the first Middle East report. Seizure 2014;23:570–572.
    1. Kim SH, Kang HC, Lee EJ, et al. Low glycemic index treatment in patients with drug‐resistant epilepsy. Brain Dev 2017;39:687–692.
    1. Wirrell EC, Darwish HZ, Williams‐Dyjur C, et al. Is a fast necessary when initiating the ketogenic diet? J Child Neurol 2002;17:179–182.
    1. Nathan JK, Purandare AS, Parekh ZB, et al. Ketogenic diet in Indian children with uncontrolled epilepsy. Indian Pediatr 2009;46:669–673.
    1. Bergqvist AG, Schall JI, Gallagher PR, et al. Fasting versus gradual initiation of the ketogenic diet: a prospective, randomized clinical trial of efficacy. Epilepsia 2005;46:1810–1819.
    1. Kim DW, Kang HC, Park JC, et al. Benefits of the nonfasting ketogenic diet compared with the initial fasting ketogenic diet. Pediatrics 2004;114:1627–1630.
    1. Freeman JM, Vining EPG. Seizures decrease rapidly after fasting: preliminary studies of the ketogenic diet. Arch Pediatr Adolesc Med 1999;153:946–949.
    1. Kossoff EH, Laux LC, Blackford R, et al. When do seizures improve with the ketogenic diet? Epilepsia 2008;49:329–333.
    1. van der Louw EJ, Desadien R, Vehmeijer FO, et al. Concomitant lamotrigine use is associated with decreased efficacy of the ketogenic diet in childhood refractory epilepsy. Seizure 2015;32:75–77.
    1. Zarnowska I, Luszczki JJ, Zarnowski T, et al. Pharmacodynamic and pharmacokinetic interactions between common antiepileptic drugs and acetone, the chief anticonvulsant ketone body elevated in the ketogenic diet in mice. Epilepsia 2009;50:1132–1140.
    1. Kossoff EH, Pyzik PL, Rubenstein JE, et al. Combined ketogenic diet and vagus nerve stimulation: rational polytherapy? Epilepsia 2007;48:77–81.
    1. Dahlin MG, Beck OM, Amark PE. Plasma levels of antiepileptic drugs in children on the ketogenic diet. Pediatr Neurol 2006;35:6–10.
    1. Coppola G, Verrotti A, D'Aniello A, et al. Valproic acid and phenobarbital blood levels during the first month of treatment with the ketogenic diet. Acta Neurol Scand 2010;122:303–307.
    1. Heo G, Kim SH, Chang MJ. Effect of ketogenic diet and other dietary therapies on anti‐epileptic drug concentrations in patients with epilepsy. J Clinc Pharm Ther 2017;42:758–764.
    1. Lyczkowski DA, Pfeifer HH, Ghosh S, et al. Safety and tolerability of the ketogenic diet in pediatric epilepsy: effects of valproate combination therapy. Epilepsia 2005;46:1533–1538.
    1. Spilioti M, Pavlou E, Gogou M, et al. Valproate effect on ketosis in children under ketogenic diet. Eur J Paediatr Neurol 2016;20:555–559.
    1. Stevens CE, Turner Z, Kossoff EH. Hepatic dysfunction as a complication of combined ketogenic diet and valproic acid. Pediatr Neurol 2016;54:82–84.
    1. Coppola G, Epifanio G, Auricchio G, et al. Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet. Brain Dev 2006;28:358–365.
    1. Takeoka M, Riviello JJ, Pfeifer H, et al. Concomitant treatment with topiramate and ketogenic diet in pediatric epilepsy. Epilepsia 2002;43:1072–1075.
    1. Kossoff EH, Pyzik PL, Furth SL, et al. Kidney stones, carbonic anhydrase inhibitors, and the ketogenic diet. Epilepsia 2002;43:1168–1171.
    1. Paul E, Conant KD, Dunne IE, et al. Urolithiasis on the ketogenic diet with concurrent topiramate or zonisamide therapy. Epilepsy Res 2010;90:151–156.
    1. McNally MA, Pyzik PL, Rubenstein JE, et al. Empiric use of oral potassium citrate reduces symptomatic kidney stone incidence with the ketogenic diet. Pediatrics 2009;124:e300–e304.
    1. Kossoff EH, Pyzik PL, McGrogan JR, et al. Impact of early versus late anticonvulsant reduction after ketogenic diet initiation. Epilepsy Behav 2004;5:499–502.
    1. Lebel D, Morin C, Laberge M, et al. The carbohydrate and caloric content of concomitant medications for children with epilepsy on the ketogenic diet. Can J Neurol Sci 2001;28:322–340.
    1. Vestergaard P. Effects of antiepileptic drugs on bone health and growth potential in children with epilepsy. Paediatr Drugs 2015;17:141–150.
    1. Bergqvist AG, Schall JI, Stallings VA. Vitamin D status in children with intractable epilepsy, and impact of the ketogenic diet. Epilepsia 2007;48:66–71.
    1. Christodoulides SS, Neal EG, Fitzsimmons G, et al. The effect of the classical and medium chain triglyceride ketogenic diet on vitamin and mineral levels. J Hum Nutr Diet 2012;25:16–26.
    1. Arslan N, Kose E, Guzel O. The effect of ketogenic diet on serum selenium levels in patients with intractable epilepsy. Biol Trace Elem Res 2017;178:1–6.
    1. Bergqvist AG, Chee CM, Lutchka L, et al. Selenium deficiency with cardiomyopathy: a complication of the ketogenic diet. Epilepsia 2003;44:618–620.
    1. Bank IM, Shemie SD, Rosenblatt B, et al. Sudden cardiac death in association with the ketogenic diet. Pediatr Neurol 2008;39:429–431.
    1. Sirikonda NS, Patten WD, Phillips JR, et al. Ketogenic diet: rapid onset of selenium deficiency‐induced cardiac decompensation. Pediatr Cardiol 2012;33:834–838.
    1. Sampath A, Kossoff EH, Furth SL, et al. Kidney stones and the ketogenic diet: risk factors and prevention. J Child Neurol 2007;22:375–378.
    1. Benn A, Swan CHJ, Cooke WT, et al. Effect of intralumninal pH on the absorption of pteroylmonoglutamic acid. British Med J 1971;1:148–150.
    1. Kang HC, Chung DE, Kim DW, et al. Early and late‐onset complications of the ketogenic diet for intractable epilepsy. Epilepsia 2004;45:1116–1123.
    1. Berry‐Kravis E, Booth G, Sanchez AC, et al. Carnitine levels and the ketogenic diet. Epilepsia 2001;42:1445–1451.
    1. Alberti MJ, Agustinho A, Argumedo L, et al. Recommendations for the clinical management of children with refractory epilepsy receiving the ketogenic diet. Arch Argent Pediatr 2016;114:56–63.
    1. AAP Committee on Nutrition . Ketogenic diet In Kleinman RE, Greer FR. (Eds) Pediatric nutrition. 7th Ed Itasca, IL: AAP Press; 2013:1147–1166.
    1. Selter JH, Turner Z, Doerrer SC, et al. Dietary and medication adjustments to improve seizure control in patients treated with the ketogenic diet. J Child Neurol 2015;30:53–57.
    1. Gilbert DL, Pyzik PL, Freeman JM. The ketogenic diet: seizure control correlates better with serum beta‐hydroxybutyrate than with urine ketones. J Child Neurol 2000;15:787–790.
    1. Van Delft R, Lambrechts D, Verschuure P, et al. Blood betahydroxybutyrate correlates better with seizures reduction due to ketogenic diet than urine ketosis. Seizure 2010;19:36–39.
    1. Buchhalter JR, D'Alfonso S, Connolly M, et al. The relationship between D‐beta‐hydroxybutyrate blood concentrations and seizure control in children treated with the ketogenic diet for medically intractable epilepsy. Epilepsia Open 2017;2:317–321.
    1. Kwiterovich PO Jr, Vining EP, Pyzik P, et al. Effect of a high‐fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children. JAMA 2003;290:912–920.
    1. Bergqvist AGC, Schall JI, Stallings VA, et al. Progressive bone mineral content loss in children with intractable epilepsy treated with the ketogenic diet. Am J Clin Nutr 2008;88:1678–1684.
    1. Spulber G, Spulber S, Hagenas L, et al. Growth dependence on insulin‐like growth factor‐1 during the ketogenic diet. Epilepsia 2009;50:297–303.
    1. Kessler SK, Gallagher PR, Shellhaas RA, et al. Early EEG improvement after ketogenic diet initiation. Epilepsy Res 2011;94:94–101.
    1. Hamdy RF, Turner Z, Pyzik PL, et al. Lack of influence of body mass index on the efficacy of the ketogenic diet. J Child Neurol 2007;22:1167–1171.
    1. Ballaban‐Gil K, Callahan C, O'Dell C, et al. Complications of the ketogenic diet. Epilepsia 1998;39:744–748.
    1. Wheless JW. The Ketogenic Diet: an effective medical therapy with side effects. J Child Neurol 2001;16:633–635.
    1. Caraballo R, Vaccarezza M, Cersósimo R, et al. Long‐term follow‐up of the ketogenic diet for refractory epilepsy: multicenter Argentinean experience in 216 pediatric patients. Seizure 2011;20:640–645.
    1. Zamani GR, Mohammadi M, Ashrafi MR, et al. The effects of classic ketogenic diet on serum lipid profile in children with refractory seizures. Acta Neurol Belg 2016;116:529–534.
    1. Liu YM, Lowe H, Zak MM, et al. Can children with hyperlipidemia receive ketogenic diet for medication‐resistant epilepsy? J Child Neurol 2013;28:479–483.
    1. Nizamuddin J, Turner Z, Rubenstein JE, et al. Management and risk factors for dyslipidemia with the ketogenic diet. J Child Neurol 2008;23:758–761.
    1. Guzel O, Yılmaz U, Uysal U, et al. The effect of olive oil‐based ketogenic diet on serum lipid levels in epileptic children. Neurol Sci 2016;37:465–470.
    1. Groesbeck DK, Bluml RM, Kossoff EH. Long‐term use of the ketogenic diet in the treatment of epilepsy. Dev Med Child Neurol 2006;48:978–981.
    1. Doksöz O, Güzel O, Yılmaz U, et al. The short‐term effect of ketogenic diet on carotid intima‐media thickness and elastic properties of the carotid artery and the aorta in epileptic children. J Child Neurol 2015;30:1646–1650.
    1. Ozdemir R, Güzel O, Küçük M, et al. The effect of the ketogenic diet on the vascular structure and functions in children with intractable epilepsy. Pediatr Neurol 2016;56:30–34.
    1. Coppola G, Natale F, Torino A, et al. The impact of the ketogenic diet on arterial morphology and endothelial function in children and young adults with epilepsy: a case‐control study. Seizure 2014;23:260–265.
    1. Kapetanakis M, Liuba P, Odermarsky M, et al. Effects of ketogenic diet on vascular function. Eur J Paediatr Neurol 2014;18:489–494.
    1. Furth SL, Casey JC, Pyzik PL, et al. Risk factors for urolithiasis in children on the ketogenic diet. Pediatric Nephrol 2000;15:125–128.
    1. Vining EP, Pyzik P, McGrogan J, et al. Growth of children on the ketogenic diet. Dev Med Child Neurol 2002;44:796–802.
    1. Williams S, Basualdo‐Hammond C, Curtis R, et al. Growth retardation in children with epilepsy on the ketogenic diet: a retrospective chart review. J Am Diet Assoc 2002;102:405–407.
    1. Peterson SJ, Tangney CC, Pimentel‐Zablah EM, et al. Changes in growth and seizure reduction in children on the ketogenic diet as a treatment for intractable epilepsy. J Am Diet Assoc 2005;105:718–725.
    1. Best TH, Franz DN, Gilbert DL, et al. Cardiac complications in pediatric patients on the ketogenic diet. Neurology 2000;54:2328–2330.
    1. Sharma S, Gulati S. The ketogenic diet and the QT interval. J Clin Neurosci 2012;18:181–182.
    1. Stewart WA, Gordon K, Camfield P. Acute pancreatitis causing death in a child on the ketogenic diet. J Child Neurol 2001;16:682.
    1. Taub KS, Kessler SK, Bergqvist AG. Risk of seizure recurrence after achieving initial seizure freedom on the ketogenic diet. Epilepsia 2014;55:579–583.
    1. Veggiotti P, De Giorgis V. Dietary treatments and new therapeutic perspective in GLUT1 deficiency syndrome. Curr Treat Options Neurol 2014;16:291.
    1. Kang HC, Lee YJ, Lee JS, et al. Comparison of short‐versus long‐term ketogenic diet for intractable infantile spasms. Epilepsia 2011;52:781–787.
    1. Martinez CC, Pyzik PL, Kossoff EH. Discontinuing the ketogenic diet in seizure‐free children: recurrence and risk factors. Epilepsia 2007;48:187–190.
    1. Worden LT, Turner Z, Pyzik PL, et al. Is there an ideal way to discontinue the ketogenic diet? Epilepsy Res 2011;95:232–236.
    1. Patel A, Pyzik PL, Turner Z, et al. Long‐term outcomes of children treated with the ketogenic diet in the past. Epilepsia 2010;51:1277–1282.
    1. Gano LB, Patel M, Rho JM. Ketogenic diets, mitochondria, and neurological diseases. J Lipid Res 2014;55:2211–2228.
    1. Rogawski MA, Löscher W, Rho JM. Mechanisms of action of antiseizure drugs and the ketogenic diet. Cold Spring Harb Perspect Med 2016;2:6.
    1. Youm YH, Nguyen KY, Grant RW, et al. The ketone metabolite β‐hydroxybutyrate blocks NLRP3 inflammasome‐mediated inflammatory disease. Nat Med 2015;21:263–269.
    1. Rho JM, Sankar R. The ketogenic diet in a pill: is this possible? Epilepsia 2008;49(Suppl. 8):127–133.
    1. Garriga‐Canut M, Schoenike B, Qazi R, et al. 2‐Deoxy‐D‐glucose reduces epilepsy progression by NRSF‐CtBP‐dependent metabolic regulation of chromatin structure. Nat Neurosci 2006;9:1382–1387.
    1. Bialer M, Johannessen SI, Levy RH, et al. Progress report on new antiepileptic drugs: a summary of the Thirteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIII). Epilepsia 2017;58:181–221.
    1. Kovac S, Abramov AY, Walker MC. Energy depletion in seizures: anaplerosis as a strategy for future therapies. Neuropharmacology 2013;69:96–104.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit